Enanta Pharmaceuticals, Inc. (ENTA)
14.74
+1.26
(+9.30%)
USD |
NASDAQ |
Feb 24, 16:00
14.88
+0.14
(+0.92%)
After-Hours: 16:19
Enanta Pharmaceuticals Research and Development Expense (Quarterly) : 20.86M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Agios Pharmaceuticals, Inc. | 86.79M |
| ACADIA Pharmaceuticals, Inc. | 87.83M |
| Alnylam Pharmaceuticals, Inc. | 372.22M |
| Savara, Inc. | 20.59M |
| BioMarin Pharmaceutical, Inc. | 188.52M |